Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-22
2007-05-22
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S571000
Reexamination Certificate
active
10474943
ABSTRACT:
A novel pyrrole derivative represented by the following formula (1) and a salt thereof:wherein R1means substituted alkenyl, etc.; R2means substituted benzoyl, etc.; and R3to R5each means hydrogen, alkyl, halogeno, etc. The derivative and salt have antidiabetic activity.
REFERENCES:
patent: 6310217 (2001-10-01), Lehr
patent: 98/05637 (1998-02-01), None
patent: 99/46244 (1999-09-01), None
patent: 01/53257 (2001-07-01), None
patent: 01/90067 (2001-11-01), None
Lehr, M., “Synthesis, Biological Evaluation, and Structure-Activity Relationships of 3-Acylindole-2-carboxylic Acids as Inhibitors of the Cytosolic Phospholipase A2”,J. Med. Chem.,vol. 40, pp. 2694 to 2705 (1997).
Iwai Kiyotaka
Kitoh Makoto
Maruta Katsunori
Nagata Ryu
Ushiroda Kantaro
Dainippon Sumitomo Pharma Co. ,Ltd.
Saeed Kamal A.
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Pyrrole derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrole derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrole derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3793594